Get the Stockscreener App
2.32
1.31%
0.03
After Hours:
2.32
Creative Medical Technology Holdings Inc stock is traded at $2.32, with a volume of 43,774.
It is up +1.31% in the last 24 hours and up +23.40% over the past month.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
See More
Previous Close:
$2.29
Open:
$2.26
24h Volume:
43,774
Relative Volume:
0.75
Market Cap:
$8.58M
Revenue:
$6,000
Net Income/Loss:
$-6.00M
P/E Ratio:
-1.0111
EPS:
-2.2945
Net Cash Flow:
$-5.86M
1W Performance:
+4.98%
1M Performance:
+23.40%
6M Performance:
-37.47%
1Y Performance:
+13.17%
1-Day Range:
$2.20
$2.3245
1-Week Range:
$1.9501
$2.3245
52-Week Range:
$1.504
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.32 | 8.47M | 6,000 | -6.00M | -5.86M | -2.2945 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Stock List: Research Stocks from Around the World - GuruFocus
Breakout Zone: Can Creative Medical Technology Holdings Inc continue delivering strong returns2026 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
Growth Review: What is the earnings history of Creative Medical Technology Holdings IncQuarterly Trade Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Street Watch: Does AVPTW have a sustainable dividendPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Opening: Is Sky Harbour Group Corporation being accumulated by smart money2026 Earnings Impact & Stepwise Trade Signal Guides - baoquankhu1.vn
Income Plays: Is Creative Medical Technology Holdings Inc forming bullish engulfing patternsIndex Update & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Aug Weekly: Is Starwood Property Trust Inc a top pick in the sectorLayoff News & Stepwise Trade Execution Plans - baoquankhu1.vn
New Highs: What is ACCOs market positionPortfolio Update Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long - Yahoo Finance
Leading Companies Enhancing Their Presence in the Cancer Anorexia-Cachexia Syndrome (CACS) Market - openPR.com
What are analysts price targets for Royal Caribbean Cruises LtdEntry Point & Daily Risk Controlled Trade Plans - baoquankhu1.vn
KPET Ultra Paceline Corp 2026 Audited Balance Sheet and Financial Statement Highlights - Minichart
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
NXL PE Ratio & Valuation, Is NXL Overvalued - Intellectia AI
CELZ (Creative Medical Technology Holdings) Policyholder Fu - GuruFocus
When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Sahm
Clean Energy Technologies, Inc. (CETY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Recap Report: Is Creative Medical Technology Holdings Inc stock risky to hold nowQuarterly Profit Report & Stepwise Swing Trade Plans - baoquankhu1.vn
Growth Review: What is Creative Medical Technology Holdings Incs 5 year growth outlook2026 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
Form 10-KAnnual Reports - Stock Titan
If You Invested $1,000 in Creative Med Technology Hldgs (CELZ) - Stock Titan
Aug Rallies: What is Creative Medical Technology Holdings Incs 5 year growth outlook2026 Sector Moves & Real-Time Volume Trigger Notifications - baoquankhu1.vn
BMRA PE Ratio & Valuation, Is BMRA Overvalued - Intellectia AI
Aug Weekly: Is Creative Medical Technology Holdings Inc. a strong candidate for buy and hold2026 Setups & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Creative Medical Technologies Holdings, Inc. 2025 Annual Report: Regenerative Stem Cell Therapies, Clinical Trials, and Intellectual Property Portfolio 151926293035 - Minichart
Creative Medical (NASDAQ: CELZ) details 2025 losses and regenerative trial progress - Stock Titan
Creative Medical Technology Holdings 10-K: Revenue $0.006M, EPS $(2.52) - TradingView
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Tranche Update on Creative Medical Technology Holdings, Inc.'s Equity Buyback Plan announced on June 12, 2023. - marketscreener.com
Aug Analyst Calls: What is Creative Medical Technology Holdings Incs book value per shareFed Meeting & Weekly Top Performers Watchlists - baoquankhu1.vn
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials - balticbusinessnews.com
Buybacks Report: What is Creative Medical Technology Holdings Incs book value per shareMarket Activity Summary & High Return Trade Guides - baoquankhu1.vn
Sentiment Recap: What hedge funds are buying Creative Medical Technology Holdings Inc2026 Dividend Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Aug Big Picture: Can Bridger Aerospace Group Holdings Inc Equity Warrant weather a recession - baoquankhu1.vn
CELZ Earnings History & Surprises | EPS & Revenue Results | CREATIVE MEDICAL TECHNOLOGY (NASDAQ:CELZ) - ChartMill
symbol__ Stock Quote Price and Forecast - CNN
Risk Recap: Is Calumet Inc impacted by rising rates2026 Short Interest & Smart Allocation Stock Reports - baoquankhu1.vn
EY USHome | Building a better working world - EY
Risk Analysis: Does Creative Medical Technology Holdings Inc have a competitive edge2026 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Retail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease Therapy - MSN
Shareholders reelect directors and approve governance proposals - MSN
Will iCAD Inc. stock beat EPS estimates2026 Volatility Report & Growth Oriented Trade Recommendations - Naître et grandir
Buyback Watch: Will Creative Medical Technology Holdings Inc outperform during market rallies2025 Growth vs Value & Fast Moving Stock Watchlists - baoquankhu1.vn
Fed Watch: Why is On Holding AG stock going downMarket Risk Report & Community Supported Trade Ideas - baoquankhu1.vn
Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World
Creative Medical Technology (NASDAQ:CELZ) Stock Passes Below Fifty Day Moving Average – Time to Sell? - Defense World
The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them (2026-03-03) - Seeking Alpha
Swing Trade: What hedge funds are buying Creative Medical Technology Holdings Inc2025 Growth vs Value & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
CELZ Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TIRX Stock News Today | Earnings, Events & Price Alerts - intellectia.ai
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):